Oncolytics Biotech Inc
TSX:ONC
Oncolytics Biotech Inc
TSX:ONC
Price:
1.49 CAD
Market Closed
Updated:
May 30, 2024
Oncolytics Biotech Inc
Operating Expenses
|
Oncolytics Biotech Inc
Operating Expenses Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Oncolytics Biotech Inc
TSX:ONC
|
Operating Expenses
-CA$35.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-5%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Operating Expenses
-$214.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Operating Expenses
-$167.4m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Operating Expenses
-$101.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Operating Expenses
-$238.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-40%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Operating Expenses
-CA$13.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
0%
|
See Also
What is Oncolytics Biotech Inc's Operating Expenses?
Operating Expenses
-35.8m
CAD
-35.8m
CAD
Based on the financial report for Mar 31, 2024, Oncolytics Biotech Inc's Operating Expenses amounts to -35.8m CAD.
What is Oncolytics Biotech Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%
-5%
Over the last year, the Operating Expenses growth was -31%. The average annual Operating Expenses growth rates for Oncolytics Biotech Inc have been -11% over the past three years , -16% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
